Form 8-K
8-K — Profusa, Inc.
Accession: 0001213900-26-075502
Filed: 2026-07-06
Period: 2026-07-02
CIK: 0001859807
SIC: 3841 (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)
Item: Material Modifications to Rights of Security Holders
Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item: Other Events
Item: Financial Statements and Exhibits
Documents
8-K — ea0297130-8k_profusa.htm (Primary)
EX-3.1 — CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PROFUSA, INC., FILED WITH THE SECRETARY OF STATE OF THE STATE OF DELAWARE (ea029713001ex3-1.htm)
EX-99.1 — PRESS RELEASE DATED JULY 2, 2026 (ea029713001ex99-1.htm)
GRAPHIC (ea029713001_ex99-1img1.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — CURRENT REPORT
8-K (Primary)
Filename: ea0297130-8k_profusa.htm · Sequence: 1
false
--12-31
0001859807
0001859807
2026-07-02
2026-07-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
July 2, 2026
PROFUSA, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
001-41177
86-3437271
(State or Other Jurisdiction of
Incorporation or Organization)
(Commission File No.)
(I.R.S. Employer
Identification No.)
626 Bancroft Way, Suite A
Berkeley, CA 94710
(Address of principal executive offices and zip
code)
Registrant’s telephone number, including
area code: (925) 997-6925
Not Applicable
(Former name or former address, if changed from
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol (s)
Name of each exchange on which registered
Common Stock, par value $.0001 per share
PFSA
The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.03. Material Modifications of Rights of Security Holders.
To the extent required by
Item 3.03 of Form 8-K, the information contained in Item 5.03 herein is incorporated by reference into this Item 3.03.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change
in Fiscal Year.
At the Profusa, Inc. (the
“Company”) annual meeting of stockholders completed on June 23, 2026, the stockholders of the Company approved an amendment
to the Company’s amended and restated certificate of incorporation (the “Amendment”) to effect the reverse stock split
at a ratio in the range of 1-for-5 to 1-for-200, with such ratio to be determined in the discretion of the Company’s board of directors
and with such reverse stock split to be effected at such time and date, if at all, as determined by the Company’s board of directors,
or any of its delegated authorized persons, prior to the two-year anniversary of the annual meeting.
Pursuant to such authority
granted by the Company’s stockholders, the Company’s board of directors authorized the Company’s Chief Executive Officer
to determine the final text of the Amendment, including the reverse stock split ratio, and such other changes as may be required to effectuate
the reverse stock split. Accordingly, the Company’s Chief Executive Officer approved a one-for-twenty-five (1:25) reverse stock
split (the “Reverse Stock Split”) of the Company’s common stock and the filing of the Amendment to effectuate the Reverse
Stock Split. The Amendment was filed with the Secretary of State of the State of Delaware and the Reverse Stock Split will become effective
in accordance with the terms of the Amendment at 12:01 a.m. Eastern Time on July 7, 2026 (the “Effective Time”), and the Company’s
common stock will open for trading on The Nasdaq Capital Market on July 7, 2026 on a post-split basis, under the existing ticker symbol
“PFSA” but with a new CUSIP number 74319X 306. The Amendment provides that, at the Effective Time, every twenty-five (25)
shares of the Company’s issued and outstanding common stock will automatically be combined into one issued and outstanding share
of common stock, without any change in par value per share, which will remain $0.0001.
As a result of the Reverse
Stock Split, the number of shares of common stock outstanding will be reduced from approximately 13.2 million shares to approximately
530 thousand shares, and the number of authorized shares of common stock will remain at 601 million shares. As a result of the Reverse
Stock Split, except as set forth below, proportionate adjustments will be made to the per share exercise price and/or the number of shares
issuable upon the exercise or vesting of all outstanding stock options, restricted stock unit awards, performance stock unit awards, and
warrants, which will result in a proportional decrease in the number of shares of the Company’s common stock reserved for issuance
upon exercise or vesting of such stock options, restricted stock unit awards, performance stock unit awards, and warrants, and, in the
case of stock options and warrants, a proportional increase in the exercise price of all such stock options and warrants. In addition,
the number of shares reserved for issuance under the Company’s equity incentive plan immediately prior to the Effective Time will
be reduced proportionately.
No fractional shares will
be issued as a result of the Reverse Stock Split, and instead, the Company will pay cash (without interest or deduction) equal to the
fraction of one share to which each stockholder of record would otherwise be entitled, multiplied by the closing price of its common stock
on Nasdaq on the date of effectiveness of the Reverse Stock Split. The share amounts set forth in the above paragraph do not take into
account any shares which may be paid for in connection with the foregoing treatment of fractional shares.
The summary of the Amendment
does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached
hereto as Exhibit 3.1 and is incorporated herein by reference.
1
Item 8.01 Other Events
On July 2, 2026, the Company
issued a press release to announce that it filed a certificate of amendment to its certificate of incorporation with the Secretary of
State of the State of Delaware to effect a one-for-twenty-five (1:25) reverse stock split of its common stock. A copy of the press release
is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
The tables below set forth
the impact of the Reverse Stock Split on the Company’s net loss per common share - basic and diluted and weighted average common
shares outstanding - basic and diluted, for the years ended December 31, 2025 and 2024, and the three months ended March 31, 2026 and
2025.
Dollars in thousands
except share and per share data
Pre-split(1)
Post-split
Year ended December 31,
Year ended December 31,
2025
2024
2025
2024
Net loss
$ (35,823 )
$ (9,230 )
$ (35,823 )
$ (9,230 )
Net loss per common share - basic and diluted
$ (107.01 )
$ (357.14 )
$ (2,675.35 )
$ (8,935.14 )
Weighted average common shares outstanding - basic and diluted
334,762
25,844
13,390
1,033
Pre-split(2)
Post-split
Three months ended
March 31,
Three months ended
March 31,
2026
2025
2026
2025
Net loss
$ (3,456 )
$ (2,716 )
$ (3,456 )
$ (2,716 )
Net loss per common share - basic and diluted
$ (2.05 )
$ (105.09 )
$ (51.18 )
$ (2,629.24 )
Weighted average common shares outstanding - basic and diluted
1,688,107
25,844
67,524
1,033
(1)
The pre-split amounts represent amounts from the Company’s Annual Report on Form 10-K, Note 12 for the year ended December 31, 2025.
(2)
The pre-split amounts represent amounts from the Company’s Quarterly Report on Form 10-Q, Note 11 for the three months ended March 31, 2026.
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit No.
Description
3.1
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Profusa, Inc., filed with the Secretary of State of the State of Delaware.
99.1
Press Release dated July 2, 2026
104
Cover page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURE
Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
July 6, 2026
Profusa, Inc.
By:
/s/ Ben Hwang
Name:
Ben Hwang
Title:
Chief Executive Officer
3
EX-3.1 — CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PROFUSA, INC., FILED WITH THE SECRETARY OF STATE OF THE STATE OF DELAWARE
EX-3.1
Filename: ea029713001ex3-1.htm · Sequence: 2
Exhibit 3.1
STATE OF DELAWARE
CERTIFICATE OF AMENDMENT
OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
PROFUSA, INC.
Profusa, Inc., a corporation
organized and existing under the laws of the State of Delaware (the “Corporation”) for the purpose of amending
its Amended and Restated Certificate of Incorporation in accordance with the General Corporation Law of the State of Delaware, does hereby
make and execute this Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, and does hereby certify
that:
1. Article FOUR of the Amended and Restated Certificate of Incorporation
of the Corporation, as amended to date, is hereby amended by adding the following new paragraph at the end of such article:
Reverse Stock Split. Upon the effectiveness
of the Certificate of Amendment to the certificate of incorporation first inserting this sentence (the “Reverse Split Effective
Time”), each five (5) to two hundred (200) issued shares of Common Stock as of the Reverse Split Effective Time shall automatically,
and without action on the part of the Corporation or the stockholders, be combined into one (1) validly issued, fully paid and non-assessable
share of Common Stock, without effecting a change to the par value per share of Common Stock, with the exact ratio within, and inclusive
of, five (5) to two hundred (200) shares to be determined by the Board of Directors of the Corporation (or any of its delegated authorized
persons) prior to the Reverse Split Effective Time and publicly announced by the Corporation (such combination of shares, the “Reverse
Stock Split”). The Reverse Stock Split shall occur automatically, without any action by the holders of the shares of Common
Stock and whether or not any certificates representing such shares have been surrendered to the Corporation, and each certificate that
immediately prior to the Reverse Split Effective Time represented shares of Common Stock, shall thereafter, automatically and without
presenting the same for exchange, represent that number of shares of Common Stock into which the shares of Common Stock represented by
such certificate shall have been combined, subject to any elimination of fractional interests; provided that the Corporation shall not
be obligated to issue certificates evidencing the shares of Common Stock issuable as a result of the Reverse Stock Split unless the existing
certificate(s) evidencing the applicable shares of Common Stock prior to the Reverse Stock Split are surrendered to the Corporation
(or unless the holder thereof notifies the Corporation that such certificate(s) have been lost, stolen or destroyed and executes
a lost certificate affidavit and agreement reasonably acceptable to the Corporation, which may include a requirement to post a bond, to
indemnify the Corporation against any claim that may be made against the Corporation on account of such alleged loss, theft or destruction).
Each book entry position that immediately prior to the Reverse Split Effective Time represented issued shares of Common Stock shall thereafter
represent the number of shares of Common Stock into which the shares of Common Stock represented by such book entry position has been
combined pursuant to the Reverse Stock Split, subject to any elimination of fractional interests. The Reverse Stock Split shall also apply
to any outstanding securities or rights convertible into, or exchangeable or exercisable for, Common Stock of the Corporation, and adjustments
to such securities or rights (including the treatment of any fractional shares resulting from such adjustments) shall be made in accordance
with the terms of the applicable agreements governing such securities or rights, including but not limited to the Corporation’s
2025 Equity Incentive Plan and applicable warrant agreements.
2. The foregoing amendment was duly adopted in accordance with
Section 242 of the Delaware General Corporation Law.
3. Prior to this Certificate of Amendment becoming effective,
the Chief Executive Officer, as a delegated authorized person of the Board of Directors of the Corporation, determined that each twenty-five
(25) issued shares of Common Stock be combined into one (1) validly issued, fully paid and non-assessable share of Common Stock.
4. This Certificate of Amendment shall become effective at 12:01 a.m.,
Eastern Time, on July 7, 2026.
IN WITNESS WHEREOF, I have signed this Certificate
this 30th day of June, 2026.
/s/ Ben C. Hwang
Ben C. Hwang
Chief Executive Officer
EX-99.1 — PRESS RELEASE DATED JULY 2, 2026
EX-99.1
Filename: ea029713001ex99-1.htm · Sequence: 3
Exhibit 99.1
Profusa Announces 1-for-25 Reverse
Stock Split
BERKELEY, California, July 02, 2026 (GLOBE
NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health
company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, today
announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of
the State of Delaware to effect a one-for-twenty-five (1:25) reverse stock split of its common stock. The reverse stock split will
take effect at 12:01 am (Eastern Time) on July 7, 2026, and the Company’s common stock will open for trading on The Nasdaq
Global Market on July 7, 2026 on a post-split basis, under the existing ticker symbol “PFSA” but with a new CUSIP number 74319X
306.
As a result of the reverse stock split, every
twenty-five (25) shares of the Company’s common stock issued and outstanding prior to the opening of trading on July 7, 2026, will
be consolidated into one issued and outstanding share, with no change in the nominal par value per share of $0.0001. No fractional shares
will be issued if, as a result of the reverse stock split, a stockholder of record would become entitled to a fractional share because
the number of shares of common stock they hold before the reverse stock split is not evenly divisible by the split ratio. Instead, each
stockholder of record will be entitled to receive a cash payment in lieu of a fractional share.
As a result of the reverse stock split, the number
of shares of common stock outstanding will be reduced from approximately 13.2 million shares to approximately 530 thousand shares, and
the number of authorized shares of common stock will remain at 601 million shares.
About Profusa
Based in Berkeley, California, Profusa is a commercial
stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors
in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data
for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims
to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.
“LUMEE”, “PROFUSA” and
the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China, Japan, South Korea and
Australia.
For more information, visit https://profusa.com.
Forward-Looking Statements
Certain statements in this press release (this
“Press Release”) may be considered “forward-looking statements” within the meaning of the “safe harbor”
provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include,
without limitation, the timing and completion of the reverse split. Forward-looking statements generally relate to future events or future
financial or operating performance of Profusa. In some cases, you can identify forward-looking statements by terminology such as “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “forecast,”
“future,” “intend,” “may,” “might,” “plan,” “possible,” “potential,”
“predict,” “project,” “propose,” “seek,” “should,” “strive,” “will,”
or “would” or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are
subject to risks, uncertainties, and other factors which may be beyond the control of Profusa and could cause actual results to differ
materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates
and assumptions that, while considered reasonable by Profusa and its management, are inherently uncertain. Profusa cautions you that these
statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain.
There are risks and uncertainties described in the definitive proxy/final prospectus relating to the business combination, which has been
filed with the SEC, and in other documents filed by Profusa from time to time with the SEC. These filings may identify and address other
important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking
statements. Profusa cannot assure you that the forward-looking statements in this communication will prove to be accurate.
Investor and Media Contacts:
email: info@coreir.com
phone: 1(212) 655-0924
GRAPHIC
GRAPHIC
Filename: ea029713001_ex99-1img1.jpg · Sequence: 4
Binary file (5655 bytes)
Download ea029713001_ex99-1img1.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 9
v3.26.1
Cover
Jul. 02, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Jul. 02, 2026
Current Fiscal Year End Date
--12-31
Entity File Number
001-41177
Entity Registrant Name
PROFUSA, INC.
Entity Central Index Key
0001859807
Entity Tax Identification Number
86-3437271
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
626 Bancroft Way
Entity Address, Address Line Two
Suite A
Entity Address, City or Town
Berkeley
Entity Address, State or Province
CA
Entity Address, Postal Zip Code
94710
City Area Code
925
Local Phone Number
997-6925
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, par value $.0001 per share
Trading Symbol
PFSA
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details
Name:
dei_CurrentFiscalYearEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:gMonthDayItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration